Aperio Group’s Elevance Health ELV Stock Holding History

Aperio Group’s Portfolio ELV Stock Details ELV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$84.8M	Buy	264,173 +6,955	+3%	+$2.23M	0.25%	64
2020 Q3	$69.1M	Sell	257,218 -4,325	-2%	-$1.16M	0.23%	72
2020 Q2	$68.8M	Sell	261,543 -13,486	-5%	-$3.55M	0.25%	70
2020 Q1	$62.4M	Sell	275,029 -2,526	-0.9%	-$574K	0.28%	64
2019 Q4	$83.8M	Sell	277,555 -13,087	-5%	-$3.95M	0.3%	58
2019 Q3	$69.8M	Sell	290,642 -11,724	-4%	-$2.81M	0.28%	66
2019 Q2	$85.3M	Sell	302,366 -11,748	-4%	-$3.32M	0.35%	50
2019 Q1	$90.1M	Buy	314,114 +17,389	+6%	+$4.99M	0.39%	50
2018 Q4	$77.9M	Buy	296,725 +10,282	+4%	+$2.7M	0.39%	42
2018 Q3	$78.5M	Buy	286,443 +811	+0.3%	+$222K	0.35%	54
2018 Q2	$68M	Sell	285,632 -9,560	-3%	-$2.28M	0.32%	54
2018 Q1	$64.9M	Buy	295,192 +9,259	+3%	+$2.03M	0.32%	58
2017 Q4	$64.3M	Buy	285,933 +18,180	+7%	+$4.09M	0.33%	58
2017 Q3	$50.8M	Buy	267,753 +21,037	+9%	+$3.99M	0.29%	68
2017 Q2	$46.4M	Buy	246,716 +31,577	+15%	+$5.94M	0.28%	71
2017 Q1	$35.6M	Buy	215,139 +22,723	+12%	+$3.76M	0.24%	90
2016 Q4	$27.7M	Sell	192,416 -8,485	-4%	-$1.22M	0.21%	101
2016 Q3	$25.2M	Sell	200,901 -17,339	-8%	-$2.17M	0.18%	120
2016 Q2	$28.7M	Buy	218,240 +11,600	+6%	+$1.52M	0.22%	104
2016 Q1	$28.7M	Buy	206,640 +3,713	+2%	+$516K	0.25%	93
2015 Q4	$28.3M	Buy	202,927 +39,489	+24%	+$5.51M	0.26%	85
2015 Q3	$22.9M	Buy	163,438 +21,602	+15%	+$3.02M	0.23%	99
2015 Q2	$23.3M	Buy	141,836 +9,539	+7%	+$1.57M	0.24%	92
2015 Q1	$20.4M	Buy	132,297 +7,129	+6%	+$1.1M	0.23%	99
2014 Q4	$15.7M	Buy	125,168 +1,509	+1%	+$190K	0.19%	121
2014 Q3	$14.8M	Buy	123,659 +17,521	+17%	+$2.1M	0.2%	122
2014 Q2	$11.4M	Buy	106,138 +8,083	+8%	+$870K	0.17%	156
2014 Q1	$9.76M	Buy	+98,055	New	+$9.76M	0.14%	179
2013 Q4	–	Sell	-84,721	Closed	-$7.08M	–	192
2013 Q3	$7.08M	Buy	84,721 +9,273	+12%	+$775K	0.14%	176
2013 Q2	$6.18M	Buy	+75,448	New	+$6.18M	0.15%	157